.Merck & Co.'s TIGIT plan has gone through yet another setback. Months after shuttering a stage 3...
.After a year specified by pipeline hairstyles, the departure of its own chief executive officer as ...
.Cullinan Therapeutics was actually blown away sufficient with Harbour BioMed's bispecific immune sy...
.Within this week's episode of "The Leading Pipe," our company are actually diving in to Intense Bio...
.The confetti is still soaring from Eli Lilly's celebration commemorating the approval of Alzheimer'...
.Welcome to recently's Chutes & Ladders, our roundup of significant leadership hirings, firings a...
.Following a poor revealing for Lykos Rehabs' MDMA candidate for post-traumatic stress disorder at a...
.AN2 Rehabs is actually reconsidering its business in reaction to dull midphase records, promising t...
.Merck & Co. is actually paying out $700 thousand beforehand to challenge Amgen in a blood stream...
.With Gilead Sciences almost an FDA choice for its own liver health condition drug seladelpar, the c...